Lorenz Thurner

13PUBLICATIONS
83CO-AUTHORS
AutoimmunityMolecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 27, 2026
Autoantibodies to IL-1Ra and PGRN in severe COVID-19 are associated with inflammation-induced hyperphosphorylated antigen isoforms.

|May 21, 2026
Plasmacytic markers as immunotherapeutic targets for primary CD20-negative aggressive B-cell lymphomas.

|Feb 24, 2026
Impact of Perforin 1 A91V germ line background in patients with aggressive B-NHL treated with R-CHOP.

Onur Cetin, Igor Kos, Evi Regitz

|Dec 08, 2025
Impact of Perforin 1 A91V germ line background in patients with aggressive B-NHL treated with R-CHOP.

Onur Cetin, Igor Kos, Evi Regitz

|Jun 30, 2025
Anakinra during pregnancy and lactation for corticosteroid-dependant colchicine-resistant recurrent pericarditis in a patient with neutralizing anti-interleukin-1 receptor antagonist antibodies: a case report.

Andreja Cerne Cercek, Alja Gomiscek Novak, Andreja Trojner Bregar

|Apr 16, 2025
Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma.

Evgenii Shumilov, Julia Katharina Scholz, Maximilian Seib

Pageof 3

Frequent Collaborators

5 joint publications

Onur Cetin

4 joint publications

Torben Rixecker

4 joint publications

Moritz Bewarder

4 joint publications

Eva C Schwarz